INDEPENDENT WORKFLOW AWARE USER INTERFACES FOR POWER INJECTOR SYSTEM OPERATION

    公开(公告)号:US20210353870A1

    公开(公告)日:2021-11-18

    申请号:US17386897

    申请日:2021-07-28

    Abstract: A power injector system having a power injector for enabling delivery of fluid in an injection procedure to be performed on a patient may include one or more processors; a first user interface; and a second user interface. The first user interface and the second user interface may be configured to accept a plurality of user inputs associated with control of a plurality of operations of the power injector system and display information associated with the plurality of operations. One of the first user interface and the second user interface may be proximate to the power injector and the other may be remote from the power injector. The one or more processors may be programmed and/or configured to independently control the first user interface and the second user interface based on a first user input and a next user input received from the first user interface and/or the second user interface.

    PRELOADING OF CONTRAST INJECTION PROTOCOLS INTO THE ADMINSTRATION LINE

    公开(公告)号:US20210015995A1

    公开(公告)日:2021-01-21

    申请号:US17043802

    申请日:2019-04-09

    Abstract: A fluid injector system includes a control device operably associated with at least one drive component for use in actuating a plurality of fluid containers in fluid communication with a patient through an administration line. The control device includes at least one processor programmed or configured to enable programming of a diagnostic injection protocol comprising one or more phases according to which at least one of the first and the second fluid containers are selectively actuatable by the at least one drive component to enable injection of at least one of a first fluid and a second fluid into the patient. The control device is further programmed or configured to enable selection and commencement of at least partial preloading into the administration line of at least one of the first fluid and the second fluid in accordance with the one or more phases of the diagnostic injection protocol.

Patent Agency Ranking